Aruba | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Aruba totalled $ 248 thousand in 2023. Sales of commodity group 30 from Aruba decreased by 3.84% in value terms compared to 2022. exports of commodity group 30 "Pharmaceutical products" decreased by $ 9.94 thousand (cumulative exports of commodity group 30 from Aruba amounted $258 thousand in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.224% of total exports from Aruba (cumulative merchandise exports from Aruba totalled $ 111 million in 2023). The share of commodity group 30 in total exports from Aruba decreased by 0.021 p.p. compared to 2022 (it was 0.245% in 2022 and cumulative exports from Aruba were equal to $ 105 million).
Where does Aruba export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Aruba in 2023:
- Areas, nes with a share of 74% (184 thousand US$)
- Curacao with a share of 23% (59 thousand US$)
- USA with a share of 1.82% (4.54 thousand US$)
Exports structure of 30 - Pharmaceutical products - from Aruba in 2023 represented by the following main commodity groups:
- 59% (148 thousand US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 17.1% (42 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 13.4% (33 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 8.99% (22 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.595% (1.48 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 0.008% (20 US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
The value of imports of commodity group 30 "Pharmaceutical products" to Aruba totalled $ 37 million in 2023. Sales of commodity group 30 to Aruba went up by 4.15% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 1.47 million (the value of imports of commodity group 30 to Aruba was equal to $35 million in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 2.41% of total import flow to Aruba (in 2023, total imports to Aruba amounted to $ 1.53 billion). The share of commodity group 30 in total imports to Aruba decreased by 0.001 p.p. compared to 2022 (it was 2.41% in 2022 and cumulative imports to Aruba were equal to $ 1.47 billion).
Where does Aruba import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Aruba in 2023:
- Netherlands with a share of 45% (16.8 million US$)
- Panama with a share of 26% (9.72 million US$)
- Areas, nes with a share of 15.7% (5.85 million US$)
- USA with a share of 10.2% (3.79 million US$)
- China with a share of 1.68% (623 thousand US$)
- Colombia - 192 thousand US$
- United Kingdom - 2.69 thousand US$
Imports structure of 30 - Pharmaceutical products - to Aruba in 2023 represented by the following main commodity groups:
- 72% (26 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 15.8% (5.88 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 4.65% (1.72 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 3.55% (1.31 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 3.13% (1.16 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.177% (65 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
